A Phase I, Open-Label Study of Siltuximab, an Anti-IL-6...

Clinical Cancer Research 2013 / 07 Vol. 19; Iss. 13

A Phase I, Open-Label Study of Siltuximab, an Anti-IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

Kurzrock, R., Voorhees, P. M., Casper, C., Furman, R. R., Fayad, L., Lonial, S., Borghaei, H., Jagannath, S., Sokol, L., Usmani, S. Z., van de Velde, H., Qin, X., Puchalski, T. A., Hall, B., Reddy, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-12-3349
Date:
July, 2013
File:
PDF, 450 KB
english, 2013
Conversion to is in progress
Conversion to is failed